These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 25914397)
1. Prospective multicentre clinical performance evaluation of second and third generation zotarolimus-eluting stents to treat patients with bifurcated coronary lesions. Burzotta F; Summaria F; Latib A; De Vita M; Fantoni C; Benedetto S; Turturo M; Larosa C; Manzoli A; Trani C Catheter Cardiovasc Interv; 2016 Jan; 87(1):15-22. PubMed ID: 25914397 [TBL] [Abstract][Full Text] [Related]
3. Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries). Lee JM; Park KW; Han JK; Yang HM; Kang HJ; Koo BK; Bae JW; Woo SI; Park JS; Jin DK; Jeon DW; Oh SK; Park JS; Kim DI; Hyon MS; Jeon HK; Lim DS; Kim MG; Rha SW; Her SH; Hwang JY; Kim S; Choi YJ; Kang JH; Moon KW; Jang Y; Kim HS Am J Cardiol; 2014 Nov; 114(9):1329-38. PubMed ID: 25217457 [TBL] [Abstract][Full Text] [Related]
4. Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: a procedural performance comparison with sirolimus- and everolimus-eluting stents. Burzotta F; Trani C; Talarico GP; Tommasino A; Todaro D; Coluccia V; Pirozzolo G; Niccoli G; Leone AM; Porto I; Schiavoni G; Crea F Cardiovasc Revasc Med; 2013; 14(3):122-7. PubMed ID: 23453789 [TBL] [Abstract][Full Text] [Related]
5. Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial. van der Heijden LC; Kok MM; Lam MK; Danse PW; Schramm AR; Jessurun GA; Tjon Joe Gin RM; van Houwelingen KG; Hautvast RW; Linssen GC; Sen H; Löwik MM; IJzerman MJ; Doggen CJ; von Birgelen C Clin Res Cardiol; 2016 Mar; 105(3):206-15. PubMed ID: 26329584 [TBL] [Abstract][Full Text] [Related]
6. Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions: comparison of everolimus-eluting stents with resolute zotarolimus-eluting stents. Li XT; Sun H; Zhang DP; Xu L; Ni ZH; Xia K; Liu Y; Chi YH; He JF; Li WM; Wang HS; Wang LF; Yang XC Coron Artery Dis; 2014 Aug; 25(5):405-11. PubMed ID: 24584031 [TBL] [Abstract][Full Text] [Related]
7. Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach. Burzotta F; Trani C; Todaro D; Mariani L; Talarico GP; Tommasino A; Giammarinaro M; Niccoli G; Porto I; Leone AM; Mongiardo R; Mazzari MA; Schiavoni G; Crea F JACC Cardiovasc Interv; 2011 Mar; 4(3):327-35. PubMed ID: 21435612 [TBL] [Abstract][Full Text] [Related]
8. 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention). Taniwaki M; Stefanini GG; Silber S; Richardt G; Vranckx P; Serruys PW; Buszman PE; Kelbaek H; Windecker S; J Am Coll Cardiol; 2014 Apr; 63(16):1617-25. PubMed ID: 24530680 [TBL] [Abstract][Full Text] [Related]
9. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus. Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802 [TBL] [Abstract][Full Text] [Related]
10. Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial. von Birgelen C; Sen H; Lam MK; Danse PW; Jessurun GA; Hautvast RW; van Houwelingen GK; Schramm AR; Gin RM; Louwerenburg JW; de Man FH; Stoel MG; Löwik MM; Linssen GC; Saïd SA; Nienhuis MB; Verhorst PM; Basalus MW; Doggen CJ; Tandjung K Lancet; 2014 Feb; 383(9915):413-23. PubMed ID: 24183564 [TBL] [Abstract][Full Text] [Related]
11. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A; JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416 [TBL] [Abstract][Full Text] [Related]
12. Comparison of 2-year outcomes between zotarolimus-eluting and everolimus-eluting new-generation cobalt-chromium alloy stents in real-world diabetic patients. Miyazaki T; Latib A; Panoulas VF; Miyazaki S; Costopoulos C; Sato K; Naganuma T; Kawamoto H; Daida H; Colombo A Catheter Cardiovasc Interv; 2015 Jul; 86(1):E11-8. PubMed ID: 25534499 [TBL] [Abstract][Full Text] [Related]
13. Zotarolimus- and paclitaxel-eluting stents in an all-comer population in China: the RESOLUTE China randomized controlled trial. Xu B; Yang Y; Yuan Z; Du Z; Wong SC; Généreux P; Lu S; JACC Cardiovasc Interv; 2013 Jul; 6(7):664-70. PubMed ID: 23523240 [TBL] [Abstract][Full Text] [Related]
14. Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial. Orvin K; Carrie D; Richardt G; Desmet W; Assali A; Werner G; Ikari Y; Fujii K; Goicolea J; Dangoisse V; Manari A; Saito S; Wijns W; Kornowski R Catheter Cardiovasc Interv; 2016 May; 87(6):1092-100. PubMed ID: 26268482 [TBL] [Abstract][Full Text] [Related]
15. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials. Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661 [TBL] [Abstract][Full Text] [Related]
16. Prospective study to evaluate safety and efficacy of Zotarolimus Eluting Stent (PSEZES) in patients with long coronary artery lesions. Bahuleyan CG; Krishna Kumar VV; Babu S Indian Heart J; 2015; 67(3):233-8. PubMed ID: 26138180 [TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial. von Birgelen C; Basalus MW; Tandjung K; van Houwelingen KG; Stoel MG; Louwerenburg JH; Linssen GC; Saïd SA; Kleijne MA; Sen H; Löwik MM; van der Palen J; Verhorst PM; de Man FH J Am Coll Cardiol; 2012 Apr; 59(15):1350-61. PubMed ID: 22341737 [TBL] [Abstract][Full Text] [Related]
18. The role of everolimus-eluting and resolute zotarolimus-eluting stents in the treatment of coronary bifurcations. Ferrarello S; Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Kawaguchi M; Naim C; Giannini F; Colombo A J Invasive Cardiol; 2013 Sep; 25(9):436-40. PubMed ID: 23995715 [TBL] [Abstract][Full Text] [Related]
19. Angiographic and clinical outcomes after implantation of drug eluting stents in bifurcation lesions with crush or kissing stent technique. Cheema AN; Jolly SS; Burstein JM; Sharieff W; Mohammad A; Yeoh E; Mancini GB; Cantor WJ; Kutryk MJ; Strauss BH; Chisholm RJ J Interv Cardiol; 2013 Apr; 26(2):145-52. PubMed ID: 23406435 [TBL] [Abstract][Full Text] [Related]
20. Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial. Harada Y; Colleran R; Kufner S; Giacoppo D; Rheude T; Michel J; Cassese S; Ibrahim T; Laugwitz KL; Kastrati A; Byrne RA; Cardiovasc Diabetol; 2016 Sep; 15(1):124. PubMed ID: 27586678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]